AI assistant
Snap-on Inc — Director's Dealing 2025
Dec 4, 2025
30335_dirs_2025-12-04_4e6962c8-5b18-4d68-8323-8fab1c94c8b6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Snap-on Inc (SNA)
CIK: 0000091440
Period of Report: 2025-12-03
Reporting Person: Miller Richard Thomas (VP, Gen Counsel & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-03 | Common Stock | M | 1728 | $161.18 | Acquired | 5886.3913 | Direct |
| 2025-12-03 | Common Stock | S | 1474 | $344.626 | Disposed | 4412.3913 | Direct |
| 2025-12-03 | Common Stock | S | 254 | $345.155 | Disposed | 4158.3913 | Direct |
| 2025-12-04 | Common Stock | M | 2000 | $161.18 | Acquired | 6158.3913 | Direct |
| 2025-12-04 | Common Stock | S | 923 | $347.5681 | Disposed | 5235.3913 | Direct |
| 2025-12-04 | Common Stock | S | 1077 | $348.8682 | Disposed | 4158.3913 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-03 | Stock Option (Right to Buy) | $161.18 | M | 1728 | Disposed | 2028-02-15 | Common Stock (1728) | Direct |
| 2025-12-04 | Stock Option (Right to Buy) | $161.18 | M | 2000 | Disposed | 2028-02-15 | Common Stock (2000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $155.92 | 2029-02-14 | Common Stock (4500) | 4500 | Direct |
| Stock Option (Right to Buy) | $155.34 | 2030-02-13 | Common Stock (4700) | 4700 | Direct |
| Stock Option (Right to Buy) | $189.89 | 2031-02-11 | Common Stock (2815) | 2815 | Direct |
| Stock Option (Right to Buy) | $211.67 | 2032-02-10 | Common Stock (2941) | 2941 | Direct |
| Stock Option (Right to Buy) | $249.26 | 2033-02-09 | Common Stock (2433) | 2433 | Direct |
| Stock Option (Right to Buy) | $269.00 | 2034-02-15 | Common Stock (2670) | 2670 | Direct |
| Stock Option (Right to Buy) | $339.73 | 2035-02-13 | Common Stock (2076) | 2076 | Direct |
| Restricted Stock Units | $ | 2026-02-09 | Common Stock (556) | 556 | Direct |
| Restricted Stock Units | $ | 2027-02-15 | Common Stock (576) | 576 | Direct |
| Restricted Stock Units | $ | 2028-02-13 | Common Stock (485) | 485 | Direct |
| Performance Units | $ | Common Stock (1111) | 1111 | Direct | |
| Performance Units | $ | Common Stock (1152) | 1152 | Direct | |
| Performance Units | $ | Common Stock (971) | 971 | Direct | |
| Deferred Stock Units | $ | Common Stock (963.6252) | 963.6252 | Direct |
Footnotes
F1: Includes 6.7872 shares acquired under a dividend reinvestment plan.
F2: This transaction was executed in multiple trades at prices ranging from $344.05 to $345.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F3: This transaction was executed in multiple trades at prices ranging from $345.07 to $345.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F4: This transaction was executed in multiple trades at prices ranging from $347.34 to $348.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F5: This transaction was executed in multiple trades at prices ranging from $348.39 to $349.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F6: Option fully vested.
F7: Exercise of Rule 16b-3 stock option.
F8: Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
F9: 1 for 1.
F10: The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
F11: If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
F12: If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
F13: If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
F14: Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
F15: This information is based on a plan statement dated September 30, 2025.